DENTSPLY SIRONA Inc. (NASDAQ:XRAY) has been assigned an average rating of “Hold” from the thirteen research firms that are covering the company, MarketBeat reports. Three equities research analysts have rated the stock with a sell rating, two have issued a hold rating and seven have issued a buy rating on the company. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $66.44.

A number of research analysts recently commented on XRAY shares. BidaskClub downgraded DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research note on Friday, July 28th. Zacks Investment Research downgraded DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research note on Monday, October 30th. Morgan Stanley restated an “overweight” rating and set a $69.00 price objective (up from $67.00) on shares of DENTSPLY SIRONA in a research note on Friday, October 6th. HC Wainwright restated a “buy” rating and set a $68.00 price objective on shares of DENTSPLY SIRONA in a research note on Monday, November 6th. Finally, TheStreet upgraded DENTSPLY SIRONA from a “c” rating to a “b-” rating in a research note on Friday, November 3rd.

In related news, CFO Nicholas W. Alexos bought 50,000 shares of DENTSPLY SIRONA stock in a transaction dated Monday, November 13th. The stock was acquired at an average cost of $65.85 per share, with a total value of $3,292,500.00. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Francis J. Lunger sold 8,900 shares of the company’s stock in a transaction on Monday, November 13th. The shares were sold at an average price of $65.90, for a total value of $586,510.00. The disclosure for this sale can be found here. Company insiders own 1.99% of the company’s stock.

Institutional investors have recently made changes to their positions in the stock. Alps Advisors Inc. increased its position in DENTSPLY SIRONA by 0.3% in the 2nd quarter. Alps Advisors Inc. now owns 7,523 shares of the medical instruments supplier’s stock worth $488,000 after purchasing an additional 20 shares during the last quarter. Wetherby Asset Management Inc. increased its position in DENTSPLY SIRONA by 0.6% in the 2nd quarter. Wetherby Asset Management Inc. now owns 5,004 shares of the medical instruments supplier’s stock worth $324,000 after purchasing an additional 30 shares during the last quarter. BRYN MAWR TRUST Co increased its position in DENTSPLY SIRONA by 0.5% in the 2nd quarter. BRYN MAWR TRUST Co now owns 12,064 shares of the medical instruments supplier’s stock worth $782,000 after purchasing an additional 65 shares during the last quarter. Nordea Investment Management AB increased its position in DENTSPLY SIRONA by 0.7% in the 2nd quarter. Nordea Investment Management AB now owns 10,235 shares of the medical instruments supplier’s stock worth $664,000 after purchasing an additional 75 shares during the last quarter. Finally, Louisiana State Employees Retirement System increased its position in DENTSPLY SIRONA by 0.7% in the 2nd quarter. Louisiana State Employees Retirement System now owns 14,200 shares of the medical instruments supplier’s stock worth $921,000 after purchasing an additional 100 shares during the last quarter. 94.68% of the stock is owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION WARNING: This news story was originally published by Daily Political and is owned by of Daily Political. If you are accessing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark law. The correct version of this news story can be viewed at https://www.dailypolitical.com/2017/11/24/analysts-set-dentsply-sirona-inc-xray-price-target-at-66-44.html.

DENTSPLY SIRONA (NASDAQ XRAY) traded up $0.58 during mid-day trading on Tuesday, hitting $67.59. The company had a trading volume of 1,199,100 shares, compared to its average volume of 1,651,791. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.59 and a current ratio of 2.32. The firm has a market cap of $15,510.00, a price-to-earnings ratio of 26.93, a P/E/G ratio of 2.68 and a beta of 1.27. DENTSPLY SIRONA has a twelve month low of $52.53 and a twelve month high of $67.95.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Friday, November 3rd. The medical instruments supplier reported $0.70 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.66 by $0.04. The business had revenue of $1.01 billion for the quarter, compared to analyst estimates of $978.99 million. DENTSPLY SIRONA had a positive return on equity of 7.56% and a negative net margin of 20.33%. The business’s revenue was up 5.8% compared to the same quarter last year. During the same period in the prior year, the company posted $0.66 EPS. equities research analysts forecast that DENTSPLY SIRONA will post 2.66 earnings per share for the current fiscal year.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Analyst Recommendations for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.